Vivos Therapeutics Inc Ordinary Shares VVOS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.41
- Day Range
- $0.39–0.42
- 52-Week Range
- $0.38–5.95
- Bid/Ask
- $0.41 / $0.44
- Shares Outstanding
- 13.89M
- Market Cap
- $5.83M
- Volume/Avg
- 131,523 / 2M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.25
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 268
- Website
- https://www.vivos.com
Valuation
|
Metric
|
VVOS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.25 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
VVOS
|
|---|---|
Quick Ratio | 0.22 |
Current Ratio | 0.27 |
Interest Coverage | — |
Quick Ratio
VVOS
Profitability
|
Metric
|
VVOS
|
|---|---|
Return on Assets (Normalized) | −108.80% |
Return on Equity (Normalized) | −1,384.25% |
Return on Invested Capital (Normalized) | −205.35% |
Return on Assets
VVOS
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|>b^n&@ | LOCK|pNtj | $175B | |||
| Stryker Corp
SYK
| LOCK|Qc!^@%^ | LOCK|vY | $123B | |||
| Medtronic PLC
MDT
| LOCK|Ly&lrkS | LOCK|@>&h$ | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|X%@&P% | LOCK|%<Mk< | $65B | |||
| Edwards Lifesciences Corp
EW
| LOCK|??V&l%F | LOCK|?L$y | $49B | |||
| DexCom Inc
DXCM
| LOCK|!?><^%N | LOCK|>xyC | $30B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|rCMpv$ | LOCK|pzg | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|>MS | LOCK|P!$ | $26B | |||
| Steris PLC
STE
| LOCK|LKT^$H^ | LOCK|$%pm | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|?$#Tx^!W | LOCK|b$ | $18B |
United States